ATP6V1C1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.412800E-01
Normal-vs-Stage2
7.256200E-01
Normal-vs-Stage3
2.095200E-01
Normal-vs-Stage4
9.266800E-01
Stage1-vs-Stage2
9.091400E-01
Stage1-vs-Stage3
2.584400E-01
Stage1-vs-Stage4
8.769000E-01
Stage2-vs-Stage3
3.148800E-01
Stage2-vs-Stage4
7.879000E-01
Stage3-vs-Stage4
3.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.839400E-01
Normal-vs-AfricanAmerican
6.103800E-01
Normal-vs-Asian
4.170800E-01
Caucasian-vs-AfricanAmerican
7.573200E-01
Caucasian-vs-Asian
3.983000E-01
AfricanAmerican-vs-Asian
7.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.229400E-01
Normal-vs-Female
8.700800E-01
Male-vs-Female
4.693000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.586000E-01
Normal-vs-Age(41-60Yrs)
7.820200E-01
Normal-vs-Age(61-80Yrs)
5.955800E-01
Normal-vs-Age(81-100Yrs)
6.970600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.564800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.134400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.895600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.842300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.207600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.099800E-01
Normal-vs-Daily Drinker
4.728200E-01
Normal-vs-Weekly Drinker
5.851000E-01
Normal-vs-Occasional Drinker
6.991200E-01
Normal-vs-Social Drinker
8.237400E-01
Non Drinker-vs-Daily Drinker
8.952800E-01
Non Drinker-vs-Weekly Drinker
9.601800E-01
Non Drinker-vs-Occasional Drinker
7.896200E-02
Non Drinker-vs-Social Drinker
5.458800E-01
Daily Drinker-vs-Weekly Drinker
8.582000E-01
Daily Drinker-vs-Occasional Drinker
5.063700E-02
Daily Drinker-vs-Social Drinker
4.260800E-01
Weekly Drinker-vs-Occasional Drinker
1.335580E-01
Weekly Drinker-vs-Social Drinker
6.003800E-01
Occasional Drinker-vs-Social Drinker
2.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.904800E-01
Normal-vs-Grade 2
8.548600E-01
Normal-vs-Grade 3
4.446800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.330400E-01
Grade 1-vs-Grade 3
4.244800E-01
Grade 1-vs-Grade 4
5.904800E-01
Grade 2-vs-Grade 3
1.771030E-01
Grade 2-vs-Grade 4
8.548600E-01
Grade 3-vs-Grade 4
4.446800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.468000E-01
Normal-vs-NonDiabetic
7.411800E-01
Diabetic-vs-NonDiabetic
4.740600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.266200E-01
Normal-vs-NoPancreatitis
7.499400E-01
Pancreatitis-vs-NoPancreatitis
5.862600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.476800E-01
Normal-vs-N1
7.695600E-01
N0-vs-N1
7.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.368800E-01
Normal-vs-TP53-NonMutant
7.187000E-01
TP53-Mutant-vs-TP53-NonMutant
1.500380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
